Novavax (NVAX) IV at 133 into developing Covid-19 vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. ENOV
6. AON
7. AAPL
8. AZN
9. BLSM
10. GPRO

Go back to Novavax (NVAX) IV at 133 into developing Covid-19 vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.05 +0.68 (7.26%)
Previous Close $9.37    52 Week High $9.23 
Open $9.20    52 Week Low $1.16 
Day High $10.20    P/E N/A 
Day Low $9.19    EPS $-0.30 
Volume 5,890,780